Professor Francesco Rubino

About

• Biography icon plus

  Professor Francesco Rubino, is Chair of Metabolic and Bariatric Surgery at King’s College London and Honorary Consultant Surgeon at King’s College Hospital NHS foundation Trust in London. He has held this position since October 2013. Before joining King’s he was Chief of Gastrointestinal Metabolic Surgery and Director of the Diabetes Surgery Center at Weill Cornell Medical College and New York Presbyterian Hospital in New York, USA.
  
  Prof Rubino’s clinical expertise includes laparoscopic bariatric, metabolic and upper digestive surgery, including gastric bypass, sleeve gastrectomy, gastric banding and novel procedures. He is internationally recognized as one of the world’s leaders in the practice, research and teaching of metabolic, diabetes and bariatric (weight-loss) surgery.
  
  In 2004, a study by Prof Rubino provided for the first time experimental evidence that the antidiabetes effect of certain bariatric procedures, particularly gastric bypass surgery, results from mechanisms beyond weight loss. This evidence offered a scientific rationale for surgical treatment of type 2 diabetes, including in less obese patients. Professor Rubino’s research findings and theories also points to a role of the gastrointestinal tract in the pathophysiology of diabetes and obesity.
  
  Prof Rubino was the main organizer and co-director of the Diabetes Surgery Summit (DSS), an influential international consensus conference that has recognized gastrointestinal surgery as a standard-of-care treatment option for type 2 diabetes. The guidelines from the DSS were recently published in Diabetes Care in June 2016 with the endorsement of 47 international scientific societies, including the American Diabetes Association, the International Diabetes Federation, Diabetes UK, and many national diabetes, gastroenterlogical and surgical organizations from around the world. Accompanying editorials in prestigious scientific journals such as Nature, as well as in the media, highlighted how the formal recognition of surgery as a standard treatment for diabetes represents one of the most significant changes in the management of the disease since the discovery of insulin, almost a century ago.
  
  Professor Rubino received his MD and completed his residency in general surgery at the Catholic University/Policlinico Gemelli in Rome, Italy. He completed fellowships in laparoscopic and minimally invasive surgery at the European Institute of Telesurgery in Strasbourg, France, Mount Sinai Medical Center in New York and at the Cleveland Clinic in Cleveland, Ohio.
  
  A member of many professional organizations, he is the recipient of numerous awards, has given hundreds of presentations throughout the world, and is the author of over 100 publications in major scientific journals including Nature, the New England Journal of Medicine, the Lancet, JAMA, Diabetes Care, Annals of Surgery and many others. Professor Rubino also served as Congress Director and organizer of the first 3 editions of the World Congresses on Interventional Therapies for Type 2 Diabetes first in New York City and more recently (Sept 2015) in London, bringing together over 1,000 multidisciplinary diabetes experts from 62 countries

• Clinical interests icon plus

  Laparoscopic, bariatric, metabolic and upper digestive surgery including:

  • Gastric bypass
  • Sleeve gastrectomy
  • Gastric banding